Global Ophthalmology Drugs and Devices Market, By Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation And Forecast 2015 – 2021

Date: 2016-01

“The global ophthalmology drugs and devices market is expected to grow at a CAGR of 7% for the forecasted period of 2015-2021. The market was worth $XX billion in 2014 and is expected to be $XX billion in 2021. The market is driven by various factors which include increase prevalence of eye related disorders such as glaucoma and cataract aging population, regulatory approvals to new drugs and devices, new technologies such as minimally invasive surgical devices, focus on combining drugs and device therapies and increasing economic factors such as rise in disposable income and health expenditure. The market opportunities lie in the growing awareness especially in the emerging and underdeveloped countries, demand for intraocular lenses, phacoemulsification devices and other devices and therapies. However, factors such as expiration of patents, drying pipelines and major slowdowns in economies may hamper the market growth.
The market is segmented on the basis of ophthalmic diagnostic & monitoring equipment market which includes optical coherence tomography scanners market, ultra sound imaging systems, fundus camera market, ophthalmoscopes, retinoscope and other market. The surgical devices include cataract surgery device, intraocular lens market, phacoemulsification devices, glaucoma surgery device market and others. The popular drugs include Lucentis, Eylea, Avastin, Restasis, Lumigan and Ganfort, Xalatan/Xalacom, Pataday and other. The drugs include drugs for glaucoma, retinal disorder, dry eye, allergic conjunctivitis, inflammation and conjunctivitis. The end users include hospitals, eye clinics, diagnostic centres and patients.
The major geographies include North America, Europe, Asia-Pacific and rest of the world. North America is the largest market followed by Europe and Asia pacific. The North American market is driven high awareness, availability of drugs and devices, better regulatory outreach which leads to increased trust in the devices and drugs. Asia Pacific market to have high growth rate driven by strong markets in China and India. Market includes top players such as Abbot Laboratories, Alcon Inc, Ellex Medical lasers ltd, Essilor international S.A., Allergan Inc, Bausch & Lomb Inc, Carl Zeiss Meditec AG, Johnson and Johnson and Hoya Corporation.
1. Abbot Laboratories
2. Alcon Inc
3. Ellex Medical lasers ltd
4. Essilor international S.A.
5. Allergan Inc
6. Bausch & Lomb Inc
7. Carl Zeiss Meditec AG
8. Johnson and Johnson
9. Hoya corporation
10. Pfizer Inc
11. Roche holding AG
12. Santen pharmaceutical co. ltd
13. Staar surgical company
14. Iridex corporation
15. Merc & Co. Inc
16. Nidek Co. Ltd
17. Topcon corporation
18. Novagali Pharma S.A.
19. Novartis AG
20. Nicox
21. Acucela
22. Senju
23. Bayer
24. Valeant
25. Regeneron
26. Akorn
27. Eyemed
28. Visioncare ophthalmic technologies
29. Biotech Visioncare
30. VSP

This Occams Research Report covers
1. Historical data
2. Revenue forecasts, growth rates and CAGR up to 2021
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample